• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number TBD
Device Problem Degraded (1153)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Death (1802); Cardiogenic Shock (2262)
Event Type  Death  
Manufacturer Narrative
The manufacturer is reporting this event in a conservative manner due to the device malfunction (structural valve deterioration) identified prior to the patient's death.However, at this time there is no further information available on the device functionality over time, treatment provided, and device relationship with the patient's death.Further investigation is ongoing and an update will be provided should further information be received.
 
Event Description
The manufacturer was notified on a case of early structural valve deterioration of a percival valve.As informed, a patient received the percival valve in (b)(6) 2015.Severe aortic regurgitation and moderate aortic stenosis were reported.The patient passed away in 2020 due to cardiogenic shock.No further information is presently available.
 
Manufacturer Narrative
Please note the correction in b4, f10.
 
Manufacturer Narrative
Fields updated: b4, f6, f7.The manufacturer attempted to retrieve additional information on the event, but no further information has been received to date despite the attempts.As the device was not returned for analysis and the serial number remains unknown, no further investigation is possible at this time.Based on the available information, it is not possible to establish a definitive root cause for the reported event.Structural valve deterioration is included as a possible adverse event in the perceval ifu.Thus, the event is a known inherent risk of the device.Since no further information was provided on the event, patient's clinical history, device functionality over time, the root cause of the event and the relationship between the perceval valve with the patient's death cannot be definitively stated.Should further information be provided in the future, the manufacturer will re-assess the event and provide an update to this reporting activity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
MDR Report Key10912675
MDR Text Key218484596
Report Number1718850-2020-01202
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 10/29/2020,01/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTBD
Device Catalogue NumberTBD
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/15/2020
Event Location Hospital
Date Report to Manufacturer10/29/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/26/2020
Supplement Dates Manufacturer Received10/29/2020
10/29/2020
Supplement Dates FDA Received11/26/2020
01/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
-
-